Merck Rises, Bristol-Myers Slides Following Cancer Meeting
April 16, 2018 at 12:09 PM EDT
Shares of Merck are rising this morning, while peer Bristol-Myers is sliding, after both companies presented new data on their respective cancer immunotherapy treatments at the American Association for Cancer Research annual meeting.